18 March 2026
BASF divests Aseptrol biocide business to Oxidium Technologies
Aseptrol chlorine dioxide portfolio sold; terms undisclosed. New owner will expand the technology into additional industries. Formulations, labeling, approvals and supply remain unchanged.
